Marijuana Moment
New Jersey lawmakers have passed a bill to create a psilocybin therapy pilot program and allocate $6 million in funding to support the effort.
Following its advancement through several House and Senate committees, both full chambers of the legislature approved the psychedelic measure on Monday, sending it to Gov. Phil Murphy (D).
“Studies conducted by nationally and internationally recognized medical institutions indicate that psilocybin has shown efficacy, tolerability, and safety in the treatment of a variety of behavioral health conditions,” the bill’s findings sections says, “including, but not limited to, substance use disorders, depression, anxiety disorders, and end-of-life psychological distress.”
Source – Google AI
Key Current Legislation (2026 Status)
- A3852 – Psilocybin Behavioral Health Access and Therapy Pilot Program: This bill was reported favorably by the Assembly Appropriations Committee on December 18, 2025.
- Purpose: Establishes a regulated pilot program for behavioral health access and therapy.
- Funding: Appropriates $6 million to the “Psychedelic Therapy and Research Fund”.
- Structure: Creates an 11-member Psychedelic Therapy and Research Advisory Board to oversee the program.
- PDF Link: View A3852 Full Bill Text (December 2025 Version)
